Booster effect of a third mRNA-based COVID-19 vaccine dose in patients with myeloid malignancies.

Akio Mori Masahiro Onozawa Mirei Kobayashi Shihori Tsukamoto Hajime SenjoTakashi IshioEmi YokoyamaMinoru Kanaya Koh Izumiyama Makoto SaitoHaruna MurakiMasanobu MoriokaTakanori Teshima Takeshi Kondo

Published in: Cancer medicine (2023)

The third dose of an mRNA-based COVID-19 vaccine showed a booster effect in patients with myeloid malignancies. Such a good booster response has not been reported in other haematological malignancies.

Keyphrases

coronavirus disease
sars cov
bone marrow
dendritic cells
acute myeloid leukemia
binding protein
respiratory syndrome coronavirus